Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

A health care worker prepares a dose of the Pfizer-BioNTech COVID-19 vaccine at a UHN clinic in Toronto on Jan. 7, 2021.

Nathan Denette/The Canadian Press

A month-long slowdown in Canada’s COVID-19 vaccine deliveries should end next week, with the single biggest shipment of vaccines from Pfizer and BioNTech to date and almost two million doses expected in the next month.

“We’re approaching something we’re calling the big lift,” Prime Minister Justin Trudeau said Thursday in a virtual roundtable with nurses and doctors from around Canada.

Mr. Trudeau acknowledged the struggle with deliveries, and how frustrating it has been for Canada, but he said things will get better in the weeks ahead, and even better than that in April, when Canada is expecting as many as one million doses a week.

Story continues below advertisement

But the troubles aren’t entirely over. Moderna’s next shipment on Feb. 22 will now be only two-thirds of what it was supposed to be. Pfizer’s deliveries will only meet the promised number of doses if medical professionals can adjust to extracting six doses instead of five from every vial.

COVID-19 news: Updates and essential resources about the pandemic

Is my area coming out of COVID-19 lockdown? Can I travel out-of-province? A guide to restrictions across Canada

Maj.-Gen. Dany Fortin, the military commander overseeing Canada’s vaccine distribution, says Pfizer has confirmed it will ship 403,000 doses next week, 475,000 the week after that, and then 444,000 doses in each of the first two weeks of March.

“I think it’s very promising,” said Mr. Fortin.

Canada’s vaccination efforts have slowed to a crawl since mid-January, when Pfizer slowed production at its plant in Belgium to expand it. Instead of getting 1.15 million doses of the Pfizer-BioNTech vaccine between Jan. 18 and this week, Canada was shipped 339,000 doses.

Christina Antoniou, spokeswoman for Pfizer Canada, says that work is now done and the company is on track to deliver four million doses by March 31, as stated in its contract.

Ms. Antoniou also said next week’s shipment to Canada has been authorized for export by Europe, which imposed new export transparency controls as it tries to get vaccines to its population as well.

Moderna, however, has confirmed its next shipment on Feb. 22 will be only 168,000, two-thirds of what had been promised. Moderna, which delivers once every three weeks right now, shipped 180,000 doses last week. That was only 80 per cent of the promised amount.

Story continues below advertisement

To date, Canada has received about 928,000 doses from Pfizer and 515,000 from Moderna.

Pfizer will need to ship 450,000 doses a week on average in the last two weeks of March to meet its contract for four million doses by March 31. Moderna will need to ship about 1.3 million doses in March to meet its contract to ship two million doses by the same date.

Next week also marks the first time Pfizer’s label will say the vials each contain six doses. The company found it was overfilling its vials with enough vaccine to get that sixth dose, and Health Canada agreed to the change earlier this week.

Getting that sixth dose requires the use of a low dead-volume syringe, which traps less vaccine in the needle and syringe after an injection, which goes to waste. Canada has now ordered 72 million of those syringes, and two million were delivered last week.

Mr. Fortin said those are being shipped to the provinces to be ready for Monday, though no provinces reported having yet received any as of Thursday.

Provincial governments are also concerned about how easy it will be to get that sixth dose, even with the special syringes.

Story continues below advertisement

Deputy chief public health officer Dr. Howard Njoo said Thursday about 1,800 professionals took part in an English-language training session online Wednesday to learn how to do it. There will be a second session Friday in French.

Federal officials did not answer questions Thursday about whether there is a clause in the label change approval or the contract with Pfizer, that would amend the doses being sent if Canada can’t get that sixth dose all the time.

Prime Minister Justin Trudeau says a new factory in Montreal to produce vaccines against COVID-19 could boost Canada's capacity to fight the illness if the virus persists and mutates, and will be the beginning of rebuilding Canada's domestic vaccine industry so we aren't as reliant on foreign imports in future pandemics. The Canadian Press

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters and editors.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies